Effect of VEGF treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: Dynamic contrast-enhanced magnetic resonance imaging

Journal of Neurotrauma

Volumn 26, Issue 7, 2009, Pages 1005-1016

  Patel, Chirag B ^a   Cohen, David M ^b   Ahobila Vajjula, Pallavi ^a   Sundberg, Laura M ^a   Chacko, Tessy ^a   Narayana, Ponnada A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Anaplerosis Associates Inc   (United States)

Author keywords

BBB score; Blood spinal cord barrier; DCE MRI; Spinal cord injury; VEGF

Indexed keywords

BUPRENORPHINE; ENROFLOXACIN; GADOLINIUM PENTETATE; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DATA ANALYSIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN FIELD BEHAVIOR; PERMEABILITY BARRIER; PYRAMIDAL TRACT; RAT; SCORING SYSTEM; SPINAL CORD INJURY; ANALYSIS OF VARIANCE; ANIMAL; BIOLOGICAL MODEL; BLOOD BRAIN BARRIER; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PERMEABILITY; SPINAL CORD; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; MOTOR ACTIVITY; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69249150412     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0860     Document Type: Article

References (63)

1. Ankeny, D.P., McTigue, D.M., Guan, Z., Yan, Q., Kinstler, O., Stokes, B.T., and Jakeman, L.B. (2001). Pegylated brainderived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury. Exp. Neurol. 170, 85-100.
2. Baptiste, D.C., and Fehlings, M.G. (2006). Pharmacological approaches to repair the injured spinal cord. J. Neurotrauma 23, 318-334. (Pubitemid 43726313)
3. Bartholdi, D., Rubin, B.P., and Schwab, M.E. (1997). VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci. 9, 2549-2560.
4. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
5. Benton, R.L., and Whittemore, S.R. (2003). VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem. Res. 28, 1693-1703.
6. Bilgen, M., and Narayana, P.A. (2001). A pharmacokinetic model for quantitative evaluation of spinal cord injury with dynamic contrast-enhanced magnetic resonance imaging. Magn. Reson. Med. 46, 1099-1106.
7. Bilgen, M., Abbe, R., and Narayana, P.A. (2001). Dynamic contrast-enhanced MRI of experimental spinal cord injury: in vivo serial studies. Magn. Reson. Med. 45, 614-622.
8. Bilgen, M., Dogan, B., and Narayana, P.A. (2002). In vivo assessment of blood-spinal cord barrier permeability: serial dynamic contrast enhanced MRI of spinal cord injury. Magn. Reson. Imaging 20, 337-341.
9. Bilgen, M., Abbe, R., Liu, S.J., and Narayana, P.A. (2000). Spatial and temporal evolution of hemorrhage in the hyperacute phase of experimental spinal cord injury: in vivo magnetic resonance imaging. Magn. Reson. Med. 43, 594-600.
10. Bilgen, M., Al-Hafez, B., Alrefae, T., He, Y.Y., Smirnova, I.V., Aldur, M.M., and Festoff, B.W. (2007). Longitudinal magnetic resonance imaging of spinal cord injury in mouse: changes in signal patterns associated with the inflammatory response. Magn. Reson. Imaging 25, 657-664.
11. Blight, A.R. (1991). Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J. Neurol. Sci. 103, 156-171.
12. Bocker-Meffert, S., Rosenstiel, P., Rohl, C., Warneke, N., Held-Feindt, J., Sievers, J., and Lucius, R. (2002). Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest. Ophthalmol. Vis. Sci. 43, 2021-2026.
13. Bradbury, E.J., and McMahon, S.B. (2006). Spinal cord repair strategies: why do they work? Nat. Rev. Neurosci. 7, 644-653.
14. Cain, L.D., Nie, L., Hughes, M.G., Johnson, K., Echetebu, C., Xu, G.Y., Hulsebosch, C.E., and McAdoo, D.J. (2007). Serum albumin improves recovery from spinal cord injury. J. Neurosci. Res. 85, 1558-1567.
15. Cao, Q., Zhang, Y.P., Iannotti, C., DeVries, W.H., Xu, X.M., Shields, C.B., and Whittemore, S.R. (2005). Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol. 191, Suppl 1, S3-S16. (Pubitemid 40075407)
16. Casella, G.T., Marcillo, A., Bunge, M.B., and Wood, P.M. (2002). New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp. Neurol. 173, 63-76.
17. Choi, U.H., Ha, Y., Huang, X., Park, S.R., Chung, J., Hyun, D.K., Park, H., Park, H.C., Kim, S.W., and Lee, M. (2007). Hypoxiainducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model. J. Neurosurg. Spine 7, 54-60. (Pubitemid 47067739)
18. Cohen, D.M., Patel, C.B., Ahobila-Vajjula, P., Sundberg, L.M., Chacko, T., Liu, S.J., and Narayana, P.A. (2009). Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed. 22, 332-341.
19. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039.
20. Dvorak, H.F., Nagy, J.A., Feng, D., Brown, L.F., and Dvorak, A.M. (1999). Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237, 97-132.
21. Facchiano, F., Fernandez, E., Mancarella, S., Maira, G., Miscusi, M., D'Arcangelo, D., Cimino-Reale, G., Falchetti, M.L., Capogrossi, M.C., and Pallini, R. (2002). Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J. Neurosurg. 97, 161-168. (Pubitemid 34693714)
22. Fenyes, D.A., and Narayana, P.A. (1998). In vivo echo-planar imaging of rat spinal cord. Magn. Reson. Imaging 16, 1249-1255.
23. Gordh, T., Chu, H., and Sharma, H.S. (2006). Spinal nerve lesion alters blood-spinal cord barrier function and activates astrocytes in the rat. Pain 124, 211-221. (Pubitemid 44176215)
24. Harrigan, M.R., Ennis, S.R., Masada, T., and Keep, R.F. (2002). Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery 50, 589-598. (Pubitemid 36322843)
25. Jakeman, L.B., Wei, P., Guan, Z., and Stokes, B.T. (1998). Brainderived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury. Exp. Neurol. 154, 170-184.
26. Jakeman, L.B., Guan, Z., Wei, P., Ponnappan, R., Dzwonczyk, R., Popovich, P.G., and Stokes, B.T. (2000). Traumatic spinal cord injury produced by controlled contusion in mouse. J. Neurotrauma 17, 299-319. (Pubitemid 30205483)
27. Jin, K., Mao, X.O., and Greenberg, D.A. (2006). Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling. J. Neurobiol. 66, 236-242. (Pubitemid 43202761)
28. Jin, K., Zhu, Y., Sun, Y., Mao, X.O., Xie, L., and Greenberg, D.A. (2002). Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA 99, 11946-11950.
29. Jin, K.L., Mao, X.O., and Greenberg, D.A. (2000). Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA 97, 10242-10247.
30. + cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock 29, 49-55.
31. Kawakami, A., Kitsukawa, T., Takagi, S., and Fujisawa, H. (1996). Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J. Neurobiol. 29, 1-17. (Pubitemid 26021768)
32. Krum, J.M., Mani, N., and Rosenstein, J.M. (2002). Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110, 589-604. (Pubitemid 34270531)
33. Loy, D.N., Crawford, C.H., Darnall, J.B., Burke, D.A., Onifer, S.M., and Whittemore, S.R. (2002). Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J. Comp. Neurol. 445, 308-324.
34. Maikos, J.T., and Shreiber, D.I. (2007). Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J. Neurotrauma 24, 492-507.
35. Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M.P., Mitsuda, N., and Tohyama, M. (2001). Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. Faseb J. 15, 1218-1220.
36. Mautes, A.E., Weinzierl, M.R., Donovan, F., and Noble, L.J. (2000). Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys. Ther. 80, 673-687.
37. Mills, C.D., Hains, B.C., Johnson, K.M., and Hulsebosch, C.E. (2001). Strain and model differences in behavioral outcomes after spinal cord injury in rat. J. Neurotrauma 18, 743-756. (Pubitemid 32769771)
38. Narayana, P., Abbe, R., Liu, S.J., and Johnston, D. (1999). Does loss of gray- and white-matter contrast in injured spinal cord signify secondary injury? In vivo longitudinal MRI studies. Magn. Reson. Med. 41, 315-320.
39. Narayana, P.A., Grill, R.J., Chacko, T., and Vang, R. (2004). Endogenous recovery of injured spinal cord: longitudinal in vivo magnetic resonance imaging. J. Neurosci. Res. 78, 749-759.
40. Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Hellings, P., Gorselink, M., Heymans, S., Theilmeier, G., Dewerchin, M., Laudenbach, V., Vermylen, P., Raat, H., Acker, T., Vleminckx, V., Van Den Bosch, L., Cashman, N., Fujisawa, H., Drost, M.R., Sciot, R., Bruyninckx, F., Hicklin, D.J., Ince, C., Gressens, P., Lupu, F., Plate, K.H., Robberecht, W., Herbert, J.M., Collen, D., and Carmeliet, P. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28, 131-138.
41. Popovich, P.G., Horner, P.J., Mullin, B.B., and Stokes, B.T. (1996). A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 142, 258-275.
42. Rossignol, S., Schwab, M., Schwartz, M., and Fehlings, M.G. (2007). Spinal cord injury: time to move? J. Neurosci. 27, 11782-11792. (Pubitemid 350072087)
43. Runge, V.M., Wells, J.W., Baldwin, S.A., Scheff, S.W., and Blades, D.A. (1997). Evaluation of the temporal evolution of acute spinal cord injury. Invest. Radiol. 32, 105-110.
44. Sakanaka, M., Zhu, P., Zhang, B., Wen, T.C., Cao, F., Ma, Y.J., Samukawa, K., Mitsuda, N., Tanaka, J., Kuramoto, M., Uno, H., and Hata, R. (2007). Intravenous infusion of dihydroginsenoside Rb1 prevents compressive spinal cord injury and ischemic brain damage through upregulation of VEGF and Bcl-XL. J. Neurotrauma 24, 1037-1054. (Pubitemid 47015437)
45. Scheff, S.W., Rabchevsky, A.G., Fugaccia, I., Main, J.A., and Lumpp, J.E., Jr. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193.
46. Sharma, H.S., Skottner, A., Lundstedt, T., Flardh, M., and Wiklund, L. (2006). Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying af- finity to melanocortin receptors. J. Neural Transm. 113, 463-476.
47. Shingu, H., Kimura, I., Nasu, Y., Shiotani, A., Oh-hama, M., Hijioka, A., and Tanaka, J. (1989). Microangiographic study of spinal cord injury and myelopathy. Paraplegia 27, 182-189. (Pubitemid 19176099)
48. Skold, M., Cullheim, S., Hammarberg, H., Piehl, F., Suneson, A., Lake, S., Sjogren, A., Walum, E., and Risling, M. (2000). Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci. 12, 3675-3686.
49. Sledge, G.W., Jr. (2002). Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Semin. Oncol. 29, 104-110.
50. Stokes, B.T., and Jakeman, L.B. (2002). Experimental modelling of human spinal cord injury: a model that crosses the species barrier and mimics the spectrum of human cytopathology. Spinal Cord 40, 101-109.
51. Storkebaum, E., Lambrechts, D., and Carmeliet, P. (2004). VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26, 943-954. (Pubitemid 39273068)
52. Svensson, B., Peters, M., Konig, H.G., Poppe, M., Levkau, B., Rothermundt, M., Arolt, V., Kogel, D., and Prehn, J.H. (2002). Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J. Cereb. Blood Flow Metab. 22, 1170-1175.
53. Tator, C.H., and Koyanagi, I. (1997). Vascular mechanisms in the pathophysiology of human spinal cord injury. J. Neurosurg. 86, 483-492. (Pubitemid 27097095)
54. Thurston, G., Rudge, J.S., Ioffe, E., Zhou, H., Ross, L., Croll, S.D., Glazer, N., Holash, J., McDonald, D.M., and Yancopoulos, G.D. (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463.
55. Tofts, P.S., Brix, G., Buckley, D.L., Evelhoch, J.L., Henderson, E., Knopp, M.V., Larsson, H.B., Lee, T.Y., Mayr, N.A., Parker, G.J., Port, R.E., Taylor, J., and Weisskoff, R.M. (1999). Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10, 223-232.
56. Twisk, J., and de Vente, W. (2002). Attrition in longitudinal studies. How to deal with missing data. J. Clin. Epidemiol. 55, 329-337.
57. Vaquero, J., Zurita, M., de Oya, S., and Coca, S. (1999). Vascular endothelial growth/permeability factor in spinal cord injury. J. Neurosurg. 90, 220-223. (Pubitemid 29155903)
58. Westergren, H., Farooque, M., Olsson, Y., and Holtz, A. (2001). Spinal cord blood flow changes following systemic hypothermia and spinal cord compression injury: an experimental study in the rat using Laser-Doppler flowmetry. Spinal Cord 39, 74-84. (Pubitemid 32226161)
59. Widenfalk, J., Lipson, A., Jubran, M., Hofstetter, C., Ebendal, T., Cao, Y., and Olson, L. (2003). Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 120, 951-960. (Pubitemid 36966647)
60. Xiaowei, H.,Ninghui,Z.,Wei, X., Yiping, T., and Linfeng, X. (2006). The experimental study of hypoxia-inducible factor-1alpha and its target genes in spinal cord injury. Spinal Cord 44, 35-43. (Pubitemid 43060943)
61. Zacharek, A., Chen, J., Cui, X., Li, A., Li, Y., Roberts, C., Feng, Y., Gao, Q., and Chopp, M. (2007). Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J. Cereb. Blood Flow Metab. 27, 1684-1691.
62. Zeger, S.L., and Liang, K.Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121-130.
63. Zhu, Y., Jin, K., Mao, X.O., and Greenberg, D.A. (2003). Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression. Faseb J. 17, 186-193. (Pubitemid 36164388)